Skip to content
About Us
Our Founders & Our Story
Leadership
Advisory Board
Our Team
Our Values
Investors
MicroOrganoSphere
TM
(MOS)
Technology
Precision
Oncology
Colorectal Cancer
Breast Cancer
Immuno-oncology
Drug
Development
Collaborators
News &
Publications
Careers
Contact Us
Menu
Establishing functional models of peritoneal carcinomatosis using MicroOrganoSphere (MOS) technology
Post navigation
Previous Post
MicroOrganoSpheres as a Clinically Applicable Precision Oncology Platform for the Discovery of Novel Therapies in Colorectal Cancer
Next Post
A functional immuno-oncology (IO) assay to assess patient response to immunotherapeutics in metastatic disease
vera
View posts by vera
Scroll to top
Copy
Email
